Published in Hepatitis Weekly, June 19th, 1995
None of these drugs yet exist but some could be created using currently available biotechnology, according to Alexander Varshavsky of the California Institute of Technology.
Writing in the Proceedings of the National Academy of Sciences ("Codominance and Toxins: A Path to Drugs of Nearly Unlimited Selectivity," PNAS, 1995;92:3663-7), Varshavsky argued that researchers should take advantage of the biological property of codominance to create a new class of drugs called...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.